MiguelA44031185 Profile Banner
Miguel Angel Zuleta. MD Profile
Miguel Angel Zuleta. MD

@MiguelA44031185

Followers
84
Following
137
Media
0
Statuses
33

Cardiólogo Intervencionista. Hospital Universitario San Ignacio | Clínica del Occidente | Los Cobos Medical Center Bogotá.

Bogotá, DC, Colombia
Joined January 2018
Don't wanna be here? Send us removal request.
@ValleAlfonso
Alfonso Valle
4 years
👉SGLT2i = renoprotective effects across eGFR & albuminuria in 👥 with/out T2D 👉SGLT2i are changing the renal and CV protection in DM2/nonDM👥 👉SGLT2i benefit patients with early stages & with CV and/or renal disease via @CristobMorales @olgaGonzalezAl1 & cia
3
89
175
@TCTMD
TCTMD
4 years
Introducing Prevail™ paclitaxel-coated balloon, the performance you want for treating complex lesions. Learn more: https://t.co/zHOMD3qkPz #coronaryDCB #MedtronicPrevail #complexPCI #Sponsored
0
1
0
@JEscaned
Javier Escaned
4 years
First evidence on the relevance of using SAPT in SCAD patients managed conservatively: significantly more events when DAPT was used. Results of the Italy-Spain DISCO consortium published at @ESC_Journals https://t.co/QrcbQNM07m @cardio_red1 @PCRonline @shci_sec @ESC_Journals
5
57
175
@WomensDerm
WDS
5 years
Happy Women Physicians Day! Today we honor all women physicians for Dr. Elizabeth Blackwell's 200th birthday! She was the first woman to earn a medical degree in the United States in 1849. #womensderm #womenphysicians #womenphysiciansday #womeninmedicine
0
11
4
@vgaldana
Victor G. Aldana
5 years
Por favor q a ningún “genio” se le vaya ocurrir exigir MiPress, autorización, valoración previa, etc ... para #VacunaCOVID19 🙏. Pdt. Importante cumplir con 2da dosis @ 21d según esquema #PfizerBioNTech @MinSaludCol
1
7
10
@jsenior64
Juan Senior
5 years
Terapia de denervación renal en hipertensión arterial. Evidencia de reducción de las cifras de presión arterial con los estudios que probaron el concepto. 12 meses del HTN RADIANCE SOLO demuestra sostener resultado con menos medicaciones.
jacc.org
1
3
10
@ValleAlfonso
Alfonso Valle
5 years
Summary via Dr McMurray #AHA20 about prescription #ARNI 📌who 📌when 📌how @secardiologia
0
26
67
@GreggWStone
Gregg W. Stone MD
5 years
Name all the implants you see. Be as specific as possible.
@suheildhanse
Suheil Dhanse
5 years
Hey #Cardiotwitter Identify all the foreign objects/ devices/ implanted structures in this image? No prizes though 🙂
6
20
63
@ValleAlfonso
Alfonso Valle
5 years
📅Arrancamos #WebiWIC en 🇦🇷 📌Motivos de ARNI “first option” 👥IC de novo 👥IC cardiorenal 👥Hospitalizado 👥IC “optimizada” Junto a @EduardoPerna1 Muchas gracias a @ComunidadFAC y @comiteic por invitación @MariaLorenaCo12 @clarihuerta @Jimepipi @GCursack @llemahtp
1
6
26
@PeterMatt19
Peter Matt
5 years
What a visionary medical doctor ! A. Grüntzig on "the ideal coronary catheter" 40 years ago; first PCI ⁦@Unispital_USZ⁩ on 16th September 1977. ⁦@FRuschitzka⁩ ⁦@flocuc⁩ ⁦@MatthiasBossard⁩ ⁦@Haager_PK⁩ ⁦@m_taramasso⁩ ⁦@PCRonline#pci
17
218
466
@JEscaned
Javier Escaned
5 years
Acetylcholine coronary testing is also safe in ACS: relevant for the new recommendations in NSTEMI #ESCGuidelines. Great presentation by Jennifer Tremmel at #ESCCongress at a dedicated session on intracoronary testing. @PCRonline @shci_sec @InocaInternati1
1
30
70
@EuroInterventio
EuroIntervention
5 years
"Influence of target vessel on prognostic relevance of FFR after coronary stenting" by Doyeon Hwang et al. #EIJBestOf https://t.co/CHI8XFHA3C
0
39
78
@seth_uretsky
Seth Uretsky
5 years
Scimitar anomaly of right sided pulm vein to SVC, cardiac shunt 1.4:1, and RV enlargement @SCMRorg @mmartinezheart
3
28
56
@drozgeozden
Özge Özden Kayhan
5 years
Imaging is kind of art♥️ World of colours..Images😍 That's why I am an imaging specialist😇 Heart is completely art♥️ #hart
3
14
91
@drozgeozden
Özge Özden Kayhan
5 years
12
4
39
@almucastro01
Almudena Castro Conde
5 years
¿Por qué son importantes los resultados del #DAPACKD? Porque se demuestra beneficio renal y CV en una población de alto riesgo: enfermedad renal crónica y porque este beneficio se da en pacientes con CON y SIN diabetes2. Punto de inflexión para la enfermedad renal crónica.
2
32
72
@DrJayMohan
Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI
5 years
⭐️No Reflow review: 💊IC nicardipine 50mcg (goal 400 mcg) 💊IC Adenosine (20 cc from 500cc mixed bag= 120mcg) (goal 100-200 mcg). REOPEN-AMI used adenosine 120mcg bolus followed by slow infusion of 2mg in 33ml saline over 2 min 💊IC Nitroprusside 50-300 mcg 💊IC Epi 100-400mcg
16
118
319